Skip to content
Home/Companies/Biotech/InSphero
IN

InSphero

Biotech·Switzerland·Active·3yr hold

InSphero is a biotech company, headquartered in Switzerland.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns InSphero?

InSphero is currently owned by ZEISS Ventures through ZEISS Ventures CVC (2019 vintage), since 2023.

Hand-verified · updated 2026-07-03

ZEISS Ventures
Investor
ZEISS Ventures
ZEISS Ventures CVC · 2019 · Evergreen

Key facts

HQSwitzerland
SectorBiotech
StatusActive

More from ZEISS Ventures CVC

Other portfolio companies in the same fund.

Custom Surgical
Active
MedTechGermany· 2026
Maculaser
Active
MedTechFinland· 2026
arcoris bio
Active
BiotechSwitzerland· 2025
Lidrotec
Active
Deep TechGermany· 2025
Odne
Active
MedTechSwitzerland· 2025
Surgify Medical
Active
MedTechFinland· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings